Skip to main content
Fig. 10 | Stem Cell Research & Therapy

Fig. 10

From: Intrarenal arterial administration of human umbilical cord-derived mesenchymal stem cells effectively preserved the residual renal function of diabetic kidney disease in rat

Fig. 10

Schematic of the time courses of the DKD induction and treatment procedure as well as identification of the HUCDMSCs in the kidney parenchyma. A the DKD induction time points and the time interval of HUCDMSCs intrarenal arterial injection. B Abundant HUCDMSCs (yellow arrows) were still clearly identified in the kidney parenchyma by day 14 after intrarenal arterial cell transfusion. Note that the red color of the HUCDMSCs was clearly observed under the immunofluorescent (IF) microscopic finding (400x, scale bar over the right lower corner = 20 μM) due to the fact that these cells were stained by Qtracker™. DKD = diabetic kidney disease; HUCDMSCs = human umbilical cord-derived mesenchymal stem cells; AG = aminoguanidine; STZ = streptozotocin

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512